Technical Analysis for GSD - Devonian Health Group Inc

Grade Last Price % Change Price Change
D 0.190 -2.56% -0.005
GSD closed down 2.56 percent on Friday, July 26, 2024, on 3.17 times normal volume. It was able to find support at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
Doji - Bearish? Reversal 0.00%

   Recent Intraday Alerts

Alert Time
Upper Bollinger Band Resistance about 5 hours ago
200 DMA Resistance about 6 hours ago
Gap Down Closed about 9 hours ago
Gap Down Partially Closed about 9 hours ago
Reversed from Down about 9 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, which is in Phase IIa clinical trials for the treatment of ulcerative colitis and atopic dermatitis. The company also develops value-added products for dermo-cosmetics, and distributes pharmaceutical products. In addition, it acquires drug and health product licenses. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2013 and is headquartered in Québec, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Drug Science Drugs Life Sciences Pharmaceutical Products Health Sciences Clinical Trial Pharmaceutical Industry Cannabinoid Medication Ulcer Cosmetics Pharmaceutical Sciences Atopic Dermatitis Colitis Pharmaceutical Drugs Ulcerative Colitis

Is GSD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.68
52 Week Low 0.11
Average Volume 18,690
200-Day Moving Average 0.282
50-Day Moving Average 0.189
20-Day Moving Average 0.184
10-Day Moving Average 0.172
Average True Range 0.032
RSI (14) 51.46
ADX 16.93
+DI 60.633
-DI 26.842
Chandelier Exit (Long, 3 ATRs) 0.253
Chandelier Exit (Short, 3 ATRs) 0.217
Upper Bollinger Bands 0.248
Lower Bollinger Band 0.120
Percent B (%b) 0.55
BandWidth 69.457
MACD Line -0.007
MACD Signal Line -0.007
MACD Histogram 0.0004
Fundamentals Value
Market Cap 11.93 Million
Num Shares 62.8 Million
EPS -0.05
Price-to-Earnings (P/E) Ratio -3.96
Price-to-Sales 3.69
Price-to-Book 1.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.445
Resistance 3 (R3) 0.470 0.410 0.403
Resistance 2 (R2) 0.410 0.345 0.398 0.388
Resistance 1 (R1) 0.300 0.305 0.355 0.275 0.374
Pivot Point 0.240 0.240 0.268 0.228 0.240
Support 1 (S1) 0.130 0.175 0.185 0.105 0.006
Support 2 (S2) 0.070 0.135 0.058 -0.008
Support 3 (S3) -0.040 0.070 -0.023
Support 4 (S4) -0.065